Clare Lewandowski-Fowler-Porter, Jarlath Swail, Abir Mamun, Georgia Horsman, Clare Taverner, Daniel Richardson, Suneeta Soni
{"title":"An Evaluation of post-sexual assault care guidelines using the AGREE II toolkit with a focus on prophylactic antibiotic recommendations.","authors":"Clare Lewandowski-Fowler-Porter, Jarlath Swail, Abir Mamun, Georgia Horsman, Clare Taverner, Daniel Richardson, Suneeta Soni","doi":"10.1097/OLQ.0000000000002399","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate nationally and internationally published, English-language clinical guidelines on the management of sexual assault, with a specific focus on the recommendations for antimicrobial prophylaxis for sexually transmitted infections, using the AGREE II toolkit and a bespoke assessment framework co-designed with survivors.</p><p><strong>Method: </strong>A comprehensive online search (Google, SAFEta, the TRIP database, and UpToDate) for clinical guidelines published in the past five years was performed and reported using the PRISMA guidelines. Four reviewers independently appraised each guideline using the appraisal of guidelines for research and evaluation (AGREE II) tool. An AGREE II domain score of >60% is the threshold for sufficient quality, and each guideline was rated high, average or low based on the domain percentages (five domains scoring >60%=high, 3-4 domains scoring >60%=average and ≤2 domains scoring>60%=low). A bespoke evaluation tool, developed with survivors, was applied to assess inclusive language, clarity of antimicrobial prophylaxis criteria, adherence considerations, antimicrobial stewardship, psychological impact, and follow-up guidance.</p><p><strong>Results: </strong>Sixteen guidelines met inclusion criteria from the WHO, UK, USA, Ireland and Australia. The median overall AGREE II score was 65% (IQR 42-79). The overall AGREE II score was 69% (IQR 45-81) (domain 1 (scope and purpose) 89% (IQR=80-92), domain 2 (stakeholder involvement) 75% (IQR=68-76), domain 3 (rigour of development) 42% (IQR=32-57), domain 4 (clarity of presentation) 80% (IQR=72-85), domain 5 (applicability) 56% (IQR 48=63), domain 6 (editorial independence) 69% (IQR=45-81)). Three guidelines (WHO, BASHH-UK, CDC: USA) had a high overall rating and overall scores of 6. Six guidelines met all bespoke tool criteria: BASHH, CDC, Wales, USA, Scotland, and WHO.</p><p><strong>Conclusion: </strong>Future guideline development should prioritise editorial independence, developmental rigour, and applicability.</p>","PeriodicalId":21837,"journal":{"name":"Sexually transmitted diseases","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2026-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sexually transmitted diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/OLQ.0000000000002399","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To evaluate nationally and internationally published, English-language clinical guidelines on the management of sexual assault, with a specific focus on the recommendations for antimicrobial prophylaxis for sexually transmitted infections, using the AGREE II toolkit and a bespoke assessment framework co-designed with survivors.
Method: A comprehensive online search (Google, SAFEta, the TRIP database, and UpToDate) for clinical guidelines published in the past five years was performed and reported using the PRISMA guidelines. Four reviewers independently appraised each guideline using the appraisal of guidelines for research and evaluation (AGREE II) tool. An AGREE II domain score of >60% is the threshold for sufficient quality, and each guideline was rated high, average or low based on the domain percentages (five domains scoring >60%=high, 3-4 domains scoring >60%=average and ≤2 domains scoring>60%=low). A bespoke evaluation tool, developed with survivors, was applied to assess inclusive language, clarity of antimicrobial prophylaxis criteria, adherence considerations, antimicrobial stewardship, psychological impact, and follow-up guidance.
Results: Sixteen guidelines met inclusion criteria from the WHO, UK, USA, Ireland and Australia. The median overall AGREE II score was 65% (IQR 42-79). The overall AGREE II score was 69% (IQR 45-81) (domain 1 (scope and purpose) 89% (IQR=80-92), domain 2 (stakeholder involvement) 75% (IQR=68-76), domain 3 (rigour of development) 42% (IQR=32-57), domain 4 (clarity of presentation) 80% (IQR=72-85), domain 5 (applicability) 56% (IQR 48=63), domain 6 (editorial independence) 69% (IQR=45-81)). Three guidelines (WHO, BASHH-UK, CDC: USA) had a high overall rating and overall scores of 6. Six guidelines met all bespoke tool criteria: BASHH, CDC, Wales, USA, Scotland, and WHO.
Conclusion: Future guideline development should prioritise editorial independence, developmental rigour, and applicability.
期刊介绍：
Sexually Transmitted Diseases, the official journal of the American Sexually Transmitted Diseases Association, publishes peer-reviewed, original articles on clinical, laboratory, immunologic, epidemiologic, behavioral, public health, and historical topics pertaining to sexually transmitted diseases and related fields. Reports from the CDC and NIH provide up-to-the-minute information. A highly respected editorial board is composed of prominent scientists who are leaders in this rapidly changing field. Included in each issue are studies and developments from around the world.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
